{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-000592","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2025-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.624024+00:00","generated_at":"2026-05-23T10:58:54.158008+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Renovaro receives Nasdaq deficiency notice for low bid price; 180-day cure period","bullets":["Notice dated April 14, 2025 for failure to maintain $1 minimum bid price over 30 consecutive business days.","Initial compliance period ends October 13, 2025; must close at $1.00 for 10 consecutive days.","If not cured, may qualify for second 180-day period if meeting other listing standards.","Stock continues trading under symbol RENB; Company evaluating options to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-000592","json":"https://secwatch.observer/filing/0001731122-25-000592.json","markdown":"https://secwatch.observer/filing/0001731122-25-000592.md","text":"https://secwatch.observer/filing/0001731122-25-000592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000592/0001731122-25-000592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000592/e6530_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T10:58:54.158008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1a2c7f1c9af72dc92039ad3dbbf48e18f6e25703","claim":"Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"April 14, 2025, Renovaro Inc. (the “ Company ”) received a deficiency notice from The Nasdaq Stock Market (“ Nasdaq ”) informing the Company that its common stock, par value $0.0001 per share (the “ Common Stock ”), fails to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Common Stock for the 30 consecutive business days prior to the date of the notice from Nasdaq. Nasdaq’s notice has no immediate effect on the listing of the Common Stock on The Nasdaq Capital Market an","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000592/0001731122-25-000592-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}